5 years ago

Thriva Raises €4.4 Million to Expand At-Home Blood Testing Service

  • Thriva, a UK-based startup offering at-home blood tests for proactive health management, has secured a €4.4 million extension to its Series A funding round from Target Global's Early Stage Fund II

  • This investment brings Thriva's total funding to around €12 million

  • The company plans to use the funds to expand its at-home health service and continue to put better health in people's hands

  • Thriva has processed over 115,000 at-home blood tests in the last four years, with 76% of users achieving an improvement in at least one of their biomarkers between tests.

      • ProblemHealthcare

      "Understanding, keeping track of, and improving what's happening inside one's body"

      Solution

      "At-home blood testing kits processed by UKAS accredited laboratories, with personalized health plans and high-quality supplements to help users achieve an improvement in at least one biomarker between tests"

      Covered on